Probably too late in the piece, but I wonder if selling the rights to Sofdra to different regions for an upfront payment and ongoing royalties may have helped avoid a potential CR for sales and marketing expenses.
DMX seems to be applying this strategy and it isn’t hurting their SP…I think the be middle east deal was only $750K but %30 on the backend. If BOT could find a partner to commit to a higher upfront investment for lower royalty rates, happy days.
First BOT post so be gentle.
BOT - Anything but charting, page-8739
-
- There are more pages in this discussion • 674 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.3¢ |
Change
-0.018(4.61%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $1.157M | 3.192M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 260813 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 48226 | 5 |
View Market Depth
| Last trade - 11.41am 25/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |